Evidence-based pharmacotherapy in cardiology. National guideline

QR Code

Evidence-based pharmacotherapy in cardiology. National guideline

.

Saved in:

Bibliographic Details
Main Authors:	S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina, V. V. Yakusevich, S. N. Tolpygina, I. V. Samorodskaya, M. M. Lukyanov, A. V. Zagrebelny, V. A. Metelskaya, E. A. Poddubskaya, O. M. Drapkina
Format:	Article
Language:	English
Published:	Столичная издательская компания 2024-03-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	evidence-based pharmacotherapy cardiology national guideline
Online Access:	https://www.rpcardio.online/jour/article/view/2992
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The role of clinical guidelines in developing quality control tools for pharmacotherapy
by: Yu. V. Lukina, et al.
Published: (2025-04-01)

NEWS FROM THE ANNUAL CONGRESS OF EUROPEAN SOCIETY OF CARDIOLOGY (BARCELONA 2014): REALIZED AND UNREALIZED EXPECTATIONS
by: S. Y. Martsevich, et al.
Published: (2015-09-01)

Issues of concern and development of classifications of the main parameters of therapy quality and compliance. Part III: quality of pharmacotherapy
by: Yu. V. Lukina, et al.
Published: (2025-02-01)

Novel approaches to the comprehensive assessment of the quality and adherence to pharmacotherapy and its use in cardiovascular patients
by: Yu. V. Lukina, et al.
Published: (2023-02-01)

PHARMACOTHERAPY QUALITY IN PATIENTS WITH ARTERIAL HYPERTENSION OBSERVED IN PRIMARY CARE PRACTICE. HYPERTENSION REGISTER DATA
by: O. M. Posnenkova, et al.
Published: (2016-01-01)

Guidelines "Medical registries. Role in evidence-based medicine. Recommendations for creation": a brief review
by: S. Yu. Martsevich, et al.
Published: (2023-07-01)

THE WAY OF ASSESSING THE ADHERENCE TO MODERN DRUG THERAPY CLINICAL GUIDELINES AIMED AT REDUCING THE RISK OF RECURRENT STROKE (ACCORDING TO THE LIS-2 REGISTER)
by: A. Yu. Suvorov, et al.
Published: (2015-09-01)

Problematic issues and development of classifications of the main parameters of quality and adherence to pharmacotherapy. Part II: physician adherence to clinical guidelines and official drug labels
by: Yu. V. Lukina, et al.
Published: (2024-03-01)

Multivariable Analysis of Primary Care Physician Adherence to Guideline-recommended Pharmacotherapy of Stable Coronary Artery Disease
by: S. K. Zyryanov, et al.
Published: (2021-03-01)

Between two ages. History of the All-Russian Scientific Society of Cardiology in columns of the Russian Journal of Cardiology from 1991 to 2001
by: Yu. V. Rodionova
Published: (2023-09-01)

Statement of Reasons of Aromatherapy Use in the Cardiologic Clinics
by: A. T. Bykov, et al.
Published: (2012-06-01)

THE CONGRESS OF THE EUROPEAN SOCIETY OF CARDIOLOGY 2010 IN STOCKHOLM: NEWS FOR PRACTITIONERS
by: S. Yu. Martsevich
Published: (2016-01-01)

CONGRESS OF EUROPEAN SOCIETY OF CARDIOLOGY IN PARIS: WHAT PRACTICAL PHYSICIAN SHOULD TAKE FOR THE NOTES
by: S. Yu. Martsevich
Published: (2016-01-01)

CLASSIFICATION OF DEFECTS PHARMACOTHERAPY AS THE BASIS OF QUALITY ASSESSMENT OF DRUG THERAPY IN HEALTHCARE
by: R. Kh. Khafisianova, et al.
Published: (2013-06-01)

The use of the level of evidence and grade of recommendations scales in developing clinical guidelines in the Russian Federation
by: N. I. Zhuravleva, et al.
Published: (2019-05-01)

ANALYSIS OF COST STRUCTURE FOR PHARMACOTHERAPY OF PATIENTS WITH STABLE ANGINA (THE CASE OF CARDIOLOGY DEPARTMENT OF TVER REGIONAL CLINICAL HOSPITAL)
by: M. A. Demidova, et al.
Published: (2015-12-01)

PECULIARITIES OF ARTERIAL HYPERTENSION DIAGNOSIS AND SECONDARY PREVENTION ACCORDING TO PHYSICIANS INTERVIEWING
by: N. S. Oganisyan, et al.
Published: (2016-01-01)

Pharmacotherapy of insomnia in childhood
by: Z. G. Tadtaeva, et al.
Published: (2022-07-01)

Pharmacotherapy algorithm for post-traumatic stress disorder
by: A. V. Vasileva, et al.
Published: (2023-10-01)

NORMAN HOLTER AND HIS METHOD OF REMOTE CARDIOLOGIC MONITORING. CASE HISTORY
by: A. A. Rassadina, et al.
Published: (2013-06-01)

News of the Annual Congress of the European Society of Cardiology in Rome: the Obvious and Proven - it's not the Same Thing
by: S. Yu. Martsevich, et al.
Published: (2016-11-01)

Current status of nuclear cardiology in the Russian Federation
by: K. V. ZavadovskyZavadovsky, et al.
Published: (2023-01-01)

Self-monitoring and treatment of chronic non-communicable diseases in the context of the COVID-19 pandemic. Consensus of experts of the National society of evidence-based pharmacotherapy and the Russian society of the prevention of non-communicable diseases
by: S. Yu. Martsevich, et al.
Published: (2020-07-01)

THE INFECTIVE ENDOCARDITIS (PREVENTION, DIAGNOSIS CRITERIA AND TREATMENT): KEY POINTS 2010
by: A. A. Demin
Published: (2016-01-01)

Modern achievements in pharmacotherapy of osteoarthritis based on endo- and phenotyping
by: I. V. Sarvilina, et al.
Published: (2021-10-01)

New framework for the development of clinical guidelines in Russia
by: D. V. Blinov, et al.
Published: (2019-07-01)

Main Approaches to Assessing the Quality of Drug Therapy in Cardiology
by: S. Yu. Martsevich, et al.
Published: (2018-09-01)

Regulatory and legal status of clinical guidelines and their role in the quality control of medical care in countries of the European Union, North America and Asia
by: V. K. Fedyaeva, et al.
Published: (2019-10-01)

THE RESULTS OF A SURVEY OF SURGEONS ON THE SAFETY OF PHARMACOTHERAPY
by: I. N. Ochakovskaya, et al.
Published: (2018-12-01)

An Attempt to Accord the Quality of Therapy of Stable Coronary Heart Disease Patients with Current Clinical Guidelines (ALIGN study): Design and the First Results
by: S. Yu. Martsevich, et al.
Published: (2020-03-01)

Therapeutic surveillance and the optimization of pharmacotherapy
by: Maria Crivineanu
Published: (2008-06-01)

News of the Annual Congress of the European Society of Cardiology in Munich: Research to Help Practical Medicine
by: S. Yu. Martsevich
Published: (2018-11-01)

News of the European Society of Cardiology Congress (London, 28 August - 2 September 2015): old drugs may be better than the new ones
by: S. Yu. Martsevich, et al.
Published: (2015-11-01)

ADVERSE EVENT OF DRUG THERAPY (THE FIRST RESULTS OF THE STUDY ACCORDING TO THE PROFILE OUTPATIENT REGISTER)
by: Yu. V. Lukina, et al.
Published: (2016-06-01)

The Impact of the Introduction of Clinical Recommendations on Cardiology in the USA and Russia Federetionon Mortality from Ischemic Heart Diseas
by: A. A. Gerasimov
Published: (2018-09-01)

Results of Surveying Cardiologists and Clinical Pharmacologists on the Selection and the Efficacy and Safety Evaluation of Pharmacotherapy for Cardiovascular Diseases
by: Yu. R. Bolsunovskaya, et al.
Published: (2022-12-01)

Adherence to Thromboprophylaxis Guidelines in Acutely ill and Immobilized patients: A Clinical Audit
by: Afsheen Sayyar, et al.
Published: (2025-06-01)

THE PROBLEM OF THE OPTIMAL PHARMACOTHERAPY CHOICE IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
by: S. R. Gilyarevskiy, et al.
Published: (2015-12-01)

Assessment of the Validity of the Psycho-Cardiological Comorbidity Index in the Practice of a Cardiologist
by: M. V. Dorofeikova, et al.
Published: (2019-05-01)

The state of the art in medical therapies for pediatric heart failure
by: Humera Ahmed, MD, et al.
Published: (2025-08-01)